Skip to content

Valproate level variation with menstrual cycle phase in bipolar disorder

Valproate level variation with menstrual cycle phase in bipolar disorder

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027184
Enrollment
Unknown
Registered
2019-11-04
Start date
2019-11-04
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

??????

Interventions

Case Series:Valproate

Sponsors

Jingzhou Mental Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Eligible participants in the study were bipolar disorder with age ranging from 18 to 35 years. All participants were inpatients, in the active phase of illness, and met DSM-IV criteria for bipolar disorder, had normal hepatic and renal panels, was stable when he was enrolled, the oral dose of valproate did not change within the last ten days before enrollment.The oral dose of valproate remained unchanged during the enrollment.

Exclusion criteria

Exclusion criteria: no exclusion ctriteria.

Design outcomes

Primary

MeasureTime frame
Valproate level;Blood progesterone level;

Countries

China

Contacts

Public ContactFeng Liu

Jingzhou Mental Hospital

ifenglau@163.com+86 15926510707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026